Latest News and Press Releases

New collaboration combines G Squared’s dedicated secondary capital with NPM’s liquidity execution platform.

Findings reinforce brilaroxazine’s treatment effect on negative symptoms and other symptom domains in schizophrenia and support clinician-assessed efficacy outcomes in a Phase 3 trial of brilaroxazine...

- CX-2051 (varsetatug masetecan) Phase 1 Colorectal Cancer expansion data on track for Q1 2026 - - Varsetatug masetecan (“Varseta-M”) Phase 1 combination study with bevacizumab in Colorectal...

MIAMI, Jan. 08, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today...

SOMERSET, N.J., Jan. 08, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced...

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung function LA JOLLA, CA, Jan. 08, 2026 (GLOBE...

MADRID and CAMBRIDGE, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics,...

SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Meltwater, a global leader in media, social, and consumer intelligence, has achieved SOC 2 Type II certification, underscoring the company's...

SANTA CLARA, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- SiTime Corporation (Nasdaq: SITM), the Precision Timing company, today announced that SiTime’s chief executive officer, Rajesh Vashist, will...

NORTH LITTLE ROCK, Ark., Jan. 08, 2026 (GLOBE NEWSWIRE) -- First Orion, a leading provider of branded calling solutions, today announced a new go-to-market collaboration with Deutsche Telekom to...